By expenditures
| Name | Title | Type |
|---|---|---|
| Margarita Rosas | Chief Financial Officer | Auditee |
| Thure Ross | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 401983 | 2025 | 2026-05-21 | CLIFTONLARSONALLEN LLP | $1.47M |
| 342339 | 2024 | 2025-02-13 | Cliftonlarsonallen LLP | $1.00M |
| 291860 | 2023 | 2024-02-23 | Cliftonlarsonallen LLP | $943,076 |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 401983 | 2025 | 2026-05-21 | 1215405 | 2025-003 | Material Weakness | Yes | B |
| 401983 | 2025 | 2026-05-21 | 1215404 | 2025-003 | Material Weakness | Yes | B |
| 401983 | 2025 | 2026-05-21 | 1215403 | 2025-003 | Material Weakness | Yes | B |
| 401983 | 2025 | 2026-05-21 | 1215402 | 2025-003 | Material Weakness | Yes | B |
| 401983 | 2025 | 2026-05-21 | 1215401 | 2025-003 | Material Weakness | Yes | B |
| 401983 | 2025 | 2026-05-21 | 1215400 | 2025-003 | Material Weakness | Yes | B |
| 401983 | 2025 | 2026-05-21 | 1215399 | 2025-003 | Material Weakness | Yes | B |
| 342339 | 2024 | 2025-02-13 | 1099518 | 2024-002 | Material Weakness | Yes | B |
| 342339 | 2024 | 2025-02-13 | 1099517 | 2024-002 | Material Weakness | Yes | B |
| 342339 | 2024 | 2025-02-13 | 523076 | 2024-002 | Material Weakness | Yes | B |
| 342339 | 2024 | 2025-02-13 | 523075 | 2024-002 | Material Weakness | Yes | B |
| 291860 | 2023 | 2024-02-23 | 946696 | 2023-003 | Significant Deficiency | - | AB |
| 291860 | 2023 | 2024-02-23 | 946695 | 2023-002 | Significant Deficiency | - | L |
| 291860 | 2023 | 2024-02-23 | 946694 | 2023-004 | Significant Deficiency | - | L |
| 291860 | 2023 | 2024-02-23 | 946693 | 2023-003 | Significant Deficiency | - | AB |
| 291860 | 2023 | 2024-02-23 | 946692 | 2023-002 | Significant Deficiency | - | L |
| 291860 | 2023 | 2024-02-23 | 370254 | 2023-003 | Significant Deficiency | - | AB |
| 291860 | 2023 | 2024-02-23 | 370253 | 2023-002 | Significant Deficiency | - | L |
| 291860 | 2023 | 2024-02-23 | 370252 | 2023-004 | Significant Deficiency | - | L |
| 291860 | 2023 | 2024-02-23 | 370251 | 2023-003 | Significant Deficiency | - | AB |
| 291860 | 2023 | 2024-02-23 | 370250 | 2023-002 | Significant Deficiency | - | L |